Detailed Result for NCT03927248
NCT ID: | NCT03927248 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 2019-04-23 |
Last Update Submitted Date: | 2020-05-05 |
Last Update Submitted Date: | 2020-05-05 |
Result First Submitted Date: | N/A |
Disposition First Submitted Date: | N/A |
Start Month Year: | September 2020 |
Start Date: | 2020-09-30 |
Start Date Type: | Anticipated |
Verification Month Year: | April 2020 |
Verification Date: | 2020-04-30 |
Completion Month Year: | December 2021 |
Completion Date: | 2021-12-31 |
Completion Date Type: | Anticipated |
Primary Completion Month Year: | September 2021 |
Primary Completion Date: | 2021-09-30 |
Primary Completion Date Type: | Anticipated |
Study first Submitted QC Date: | 2019-04-23 |
Study first posted Date: | 2019-04-25 |
Result first Submitted QC Date: | N/A |
Result First Posted Date: | N/A |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2020-05-05 |
Last Updated Posted Date: | 2020-05-07 |
Target Duration: | N/A |
Study Type: | Interventional |
Acronym: | N/A |
Baseline Population: | N/A |
Brief Title: | PAC-1 for Treatment of Refractory, Metastatic Kidney Cancer |
Official Title: | Pilot Study of Nivolumab and Procaspase Activating Compound-1 (PAC-1) for |
Overall Status: | Withdrawn |
Last Known Status: | N/A |
Phase: | Phase 1/Phase 2 |
Enrollment: | N/A |
Enrollment Type: | Actual |
Source: | HealthPartners Institute |
Limitation and Caveats: | N/A |
Number of Arms: | 1 |
Number of Groups: | N/A |
Why Stopped: | funding issues |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | N/A |
Is it FDA Regulated Drug: | true |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | N/A |
Is Biospec Retention: | N/A |
Biospec Description: | N/A |
Plan to Share IPD: | N/A |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |